A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

This Phase I/II study is testing a new drug called AZD4512, alone or in combination with other cancer treatments, in people with B-cell Non-Hodgkin Lymphoma (a type of blood cancer) that has returned or stopped responding to previous therapies. **You may be eligible if...** - You are 18 years or older - You have a confirmed diagnosis of B-cell Non-Hodgkin Lymphoma - Your lymphoma has relapsed or is refractory (not responding to prior treatment) - You are in reasonably good physical health overall **You may NOT be eligible if...** - Your lymphoma has spread to the brain or spinal fluid - You have certain specific lymphoma subtypes that are excluded - You have serious active infections or other significant health problems - You are pregnant or breastfeeding Talk to your doctor to see if this trial is right for you.